Cure Rare Disease is a biotechnology company.
Cure Rare Disease has raised $7.4M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Cure Rare Disease's investors include Muscular Dystrophy Association, California Institute for Regenerative Medicine.
Cure Rare Disease is headquartered in Boston, United States.
Cure Rare Disease is a biotechnology company.
Cure Rare Disease is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cure Rare Disease — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/cure-rare-disease. Accessed November 17, 2026.
VCBacked. (2025). Cure Rare Disease — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/cure-rare-disease
{{cite web |title=Cure Rare Disease — Funding & Investors |url=https://www.vcbacked.co/company/cure-rare-disease |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Cure Rare Disease? Request a listing update